INCIDENCE OF FALSE NEGATIVE PROSTATE CANCER SCREENING IN PATIENT TAKING 5-ALPHA REDUCTASE INHIBITORS

被引：0
|
作者：
Fram, Ethan
Maria, Pedro
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP77-16
引用
收藏
页码：E1033 / E1034
页数：2
相关论文
共 50 条
  • [21] PROSTATE BIOPSY AFTER TREATMENT WITH 5-ALPHA REDUCTASE INHIBITORS MARKEDLY ENHANCES PROSTATE CANCER DETECTION
    Kaplan, Steven
    Lee, Richard
    Chung, Doreen E.
    Scherr, Douglas
    Te, Alexis
    Vaughan, E. Darracott
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E773 - E773
  • [22] 5-alpha reductase inhibitors (5-ARI) and prostate cancer mortality among men with regular access to screening and health care
    Mucci, Lorelei A.
    Pernar, Claire Hampton
    Rencsok, Emily
    Stopsack, Konrad H.
    Grob, Sydney
    Giovannucci, Edward L.
    Olumi, Aria F.
    Kibel, Adam S.
    Preston, Mark A.
    Wilson, Kathryn M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Rates of False-Negative Screening in Prostate Specific Antigen Secondary to 5-Alpha Reductase Inhibitor Usage: A Quality-Improvement Initiative
    Loloi, Justin
    Wei, Matthew
    Babar, Mustufa
    Zhu, Denzel
    Fram, Ethan B.
    Maria, Pedro
    [J]. INTERNATIONAL BRAZ J UROL, 2022, 48 (04): : 688 - 695
  • [24] 5-Alpha reductase inhibitors in active surveillance
    Richard, Patrick O.
    Finelli, Antonio
    [J]. CURRENT OPINION IN UROLOGY, 2014, 24 (03) : 324 - 328
  • [25] PROSTATE HEALTH INDEX PREDICTS UPGRADING OF MEN ON 5-ALPHA REDUCTASE INHIBITORS
    Crawford, E. David
    Arangua, Paul
    Jones, Clifford
    Poage, Wendy
    Stone, Nelson
    La Rosa, Francisco G.
    Loeb, Stacy
    Werahera, Priya N.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E56 - E56
  • [26] Differential expression and quantitation of 5-alpha reductase (5αR) in prostate cancer
    Chikkamuniyappa, S
    McMasters, R
    Ghosh, P
    Thompson, I
    Leach, R
    Troyer, D
    [J]. MODERN PATHOLOGY, 2005, 18 : 133A - 133A
  • [27] Differential expression and quantitation of 5-alpha reductase (5αR) in prostate cancer
    Chikkamuniyappa, S
    McMasters, R
    Ghosh, P
    Thompson, I
    Leach, R
    Troyer, D
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 133A - 133A
  • [28] 5-ALPHA REDUCTASE INHIBITORS AND THE RISK OF PROSTATE CANCER MORTALITY IN MEN TREATED FOR BENIGN PROSTATIC HYPERPLASIA
    Wallner, Lauren
    DiBello, Julia
    Li, Bonnie
    Van Den Eeden, Stephen
    Weinmann, Sheila
    Ritzwoller, Debra
    Abell, Jill
    D'Agostino, Ralph, Jr.
    Loo, Ronald
    Aaronson, David
    Richert-Boe, Kathryn
    Horwitz, Ralph
    Jacobsen, Steven
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E27 - E28
  • [29] 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia
    Wallner, Lauren P.
    DiBello, Julia R.
    Li, Bonnie H.
    Van Den Eeden, Stephen K.
    Weinmann, Sheila
    Ritzwoller, Debra P.
    Abell, Jill E.
    D'Agostino, Ralph, Jr.
    Loo, Ronald K.
    Aaronson, David S.
    Richert-Boe, Kathryn
    Horwitz, Ralph I.
    Jacobsen, Steven J.
    [J]. MAYO CLINIC PROCEEDINGS, 2016, 91 (12) : 1717 - 1726
  • [30] 5-alpha reductase inhibitors and risk of male breast cancer.
    Etminan, Mahyar
    Brophy, James
    Hartzema, Abraham
    Delaney, Joseph
    Bird, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345